# Medpace Inc – FDA Inspection, Jul 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/medpace-inc/73fc50bb-105c-4d98-afdf-261bcc8d5f20
Source feed: FDA_Inspections

> FDA inspection 1245618 of Medpace Inc, July 11, 2024. Classification: No Action Indicated (NAI). 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245618
- Company Name: Medpace Inc
- Inspection Date: 2024-07-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1332930 - 2026-07-31
- FDA Inspection 1263213 - 2025-02-13
- [FDA Inspection 1232744 - 2024-03-06](https://www.keypedia.com/records/fda_inspections/medpace-inc/361b5eb5-bbfa-4117-ae30-7c27ba67b824)
- FDA Inspection 1169068 - 2022-04-26
- FDA Inspection 1145127 - 2021-05-14

## Related Officers

- [Kathryn Suttling](https://www.keypedia.com/people/kathryn-suttling/40a22409-8aba-4e9f-826b-0af51c1a7c0b)

Company: https://www.keypedia.com/companies/medpace-inc/e09bfcb9-1613-4cc0-8434-8913be0f770d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
